Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial results
Summary
NCT03482050. © 2023. The Author(s).
| Authors | Gotkine M, Caraco Y, Lerner Y, Blotnick S, Wanounou M, Slutsky SG, Chebath J, Kuperstein G, Estrin E, Ben-Hur T, Hasson A, Molakandov K, Sonnenfeld T, Stark Y, Revel A, Revel M, Izrael M |
|---|---|
| Journal | Journal of translational medicine |
| Publication Date | 2023 Feb 14;21(1):122 |
| PubMed | 36788520 |
| PubMed Central | PMC9927047 |
| DOI | 10.1186/s12967-023-03903-3 |
Research Projects
Cell Lines
- (none)